Fumarase
Fumarase, also known as fumarate hydratase, is a crucial enzyme that plays a vital role in cellular metabolism, particularly within the energy-producing pathways of the human body. Its proper function is essential for maintaining metabolic balance and overall health.

Key Takeaways
- Fumarase is an enzyme critical for the Krebs cycle, converting fumarate to malate.
- It exists in both mitochondrial and cytosolic forms, contributing to various metabolic processes.
- Deficiency in Fumarase can lead to a rare genetic disorder with severe neurological and developmental symptoms.
- The enzyme’s function is fundamental for cellular energy production and detoxification.
What is Fumarase Enzyme?
The Fumarase enzyme, also known as fumarate hydratase (FH), is a critical metalloenzyme that catalyzes the reversible hydration of fumarate to L-malate. This specific biochemical reaction is an essential step within the tricarboxylic acid (TCA) cycle, or Krebs cycle, which is the central metabolic pathway responsible for generating cellular energy in the form of ATP through aerobic respiration. In humans, Fumarase exists in two distinct isoforms: a mitochondrial form, which is directly integrated into the TCA cycle, and a cytosolic form, which participates in other metabolic processes, including the urea cycle and amino acid metabolism. The precise regulation and proper functioning of both Fumarase isoforms are indispensable for maintaining cellular energy balance, detoxification pathways, and overall metabolic homeostasis within the body.
Fumarase Function and Role in Metabolic Pathways
The primary Fumarase function in human body is its pivotal role in the Krebs cycle, where it ensures the efficient conversion of fumarate to L-malate. This step is vital for the continuous operation of the cycle, which processes acetyl-CoA derived from carbohydrates, fats, and proteins to produce reducing equivalents (NADH and FADH2). These electron carriers then fuel the electron transport chain, leading to the synthesis of the vast majority of cellular ATP. Beyond its direct contribution to energy production, the Fumarase role in metabolic pathways extends to broader cellular functions. The cytosolic Fumarase is involved in the metabolism of certain amino acids, such as arginine and phenylalanine, and contributes to the malate-aspartate shuttle, which transports reducing equivalents across the mitochondrial membrane. Furthermore, it plays a role in detoxification processes, helping to eliminate harmful metabolites and maintain cellular redox balance. Its dual localization and multifaceted roles underscore its fundamental importance in sustaining life-critical metabolic activities.
Fumarase Deficiency: Causes, Symptoms, and Impact
Fumarase deficiency is a rare, severe autosomal recessive disorder resulting from inherited mutations in the FH gene, which encodes the Fumarase enzyme. These genetic alterations lead to either a complete absence or significant reduction in functional Fumarase, causing an accumulation of fumarate and other organic acids within the body’s tissues and fluids. This metabolic imbalance is particularly detrimental to the central nervous system. The Fumarase deficiency causes symptoms that are predominantly neurological and developmental, typically manifesting in infancy or early childhood.
Key clinical features and symptoms associated with Fumarase deficiency often include:
- Profound developmental delay and severe intellectual disability
- Microcephaly, indicating impaired brain growth
- Recurrent seizures, often resistant to conventional treatment
- Severe hypotonia, affecting muscle strength and movement
- Distinctive facial features and brain malformations (e.g., polymicrogyria, simplified gyral patterns)
- Failure to thrive and feeding difficulties
The accumulation of fumarate is believed to exert neurotoxic effects, disrupting mitochondrial function and cellular signaling pathways critical for normal brain development. This condition is associated with significant morbidity and often a reduced life expectancy. Diagnosis typically involves organic acid analysis in urine, genetic testing, and enzyme activity assays. While there is currently no cure, management focuses on supportive care, seizure control, and nutritional support to alleviate symptoms and improve quality of life. Ongoing research aims to uncover more effective therapeutic strategies for this devastating disorder.



















